'Doctors said I only had two years to live'
"I'm just so happy and grateful to be alive," said Marsha, who is originally from Bristol but now lives in London.
Conn's Syndrome, also known as primary aldosteronism, is a condition that causes high blood pressure due to excessive production of the hormone aldosterone by the adrenal glands.
She has launched an affordable jewellery brand as a way to give back to the community of Bristol by raising money for local charities.
Marsha's battle began in 2005 when she collapsed at her London home and was rushed to hospital.
Despite spending six months at Park Royal Hospital, doctors were unable to identify the cause of her illness.
"They told me to go home and get my papers in order because they didn't believe I would live to see 40," Marsha recalled.
But instead of preparing for the worst, she planned a family reunion and a 40th birthday celebration, determined to embrace life.
After enduring numerous tests and consultations, she was finally diagnosed with Conn's Syndrome.
The Cleveland Clinic estimates that 5% to 10% of adults with high blood pressure have this condition, which is more prevalent in women.
Symptoms include low potassium levels, high blood pressure, headaches, muscle cramps and excessive thirst.
However, many individuals, including Marsha, do not recognise the symptoms.
"When they diagnosed me, I wasn't looking for symptoms. I just thought it was early menopause," she said.
The condition led to severe complications, including uncontrolled bleeding that led to a hysterectomy.
Marsha has since also been diagnosed with Cushing's Syndrome, another hormonal disorder caused by excessive cortisol levels.
This condition has led to the development of non-cancerous tumours, including two found on her brain and another on her vocal gland.
Due to the risk of spreading, doctors have opted not to remove the latter.
Despite her health struggles, Marsha said she tries to remain positive.
She founded an affordable jewelry brand, Queens of Jewellery, to support low-income families while raising funds for charities across the West of England.
Her products range from 50p to £25, ensuring accessibility for all.
"As a single mum, I know the struggle of choosing between a loaf of bread and treating yourself.
"I wanted to create something affordable for everyone," she explained.
Her efforts have supported charities such as Missing Link, a Bristol-based domestic abuse organisation.
Marsha said managing her condition has been challenging but she has now reduced her medication intake from 32 tablets a day to eight with the support of a pharmacist.
"I go into hospital every six months for tests, and every year my consultant reminds me that I shouldn't still be here," she said.
Despite losing her hair, mobility, and battling arthritis, Marsha said she remains calm.
"I've learned how to deal with pain, and I'm just so grateful to be alive," she said.
She said her husband has been a constant source of strength, standing by her side without "coddling" her.
Follow BBC Bristol on Facebook, X and Instagram. Send your story ideas to us on email or via WhatsApp on 0800 313 4630.
Amy Schumer reveals she has Cushing's Syndrome
'My whole world went to bits after ME diagnosis'
'I was diagnosed with endometriosis by chance'
Cushing's syndrome - NHS
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
29 minutes ago
- Business Wire
Nanochon Announces Health Canada Approval for First in Human Investigation
WASHINGTON--(BUSINESS WIRE)--Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage defects in the knee, is thrilled to announce that it was granted Health Canada Approval for their first in human clinical trial. The trial will be led by Principal Investigator, Dr. Fathi Abuzgaya, who will collaborate with Sports Medicine Specialists, Drs. Joel Lobo, Kajeandra Ravichandiran and Marcin Kowalczuk as Sub-Investigators, at the Durham Bone & Joint Specialists (DBJS), located in Ontario, Canada. Dr. Fathi Abuzgaya is an orthopedic surgeon by training and an esteemed researcher with a track record over the last 25 years, leading +600 clinical trials in all phases and therapeutic areas. 'Our team is delighted that we are the first center to start enrolling participants for the Chondrograft™ study, which represents a novel, minimally invasive treatment for patients with loss of or damaged knee cartilage,' Dr. Abuzgaya commented. 'DBJS is a multidisciplinary musculoskeletal center providing non-operative and operative treatments with accessibility to a variety of sub-specialties. Our study site with dedicated researchers enables greater, more efficient patient recruitment for clinical research and we are privileged to support Nanochon.' The Nanochon Chondrograft™ System is being evaluated in a prospective, 10 patient, early feasibility study for use in knee cartilage restoration in eligible patients between 22 and 60 years of age having femoral condyle and /or trochlea articular cartilage lesions who have failed conservative therapy, in addition to meeting other criteria. The study is designed to assess the safety and performance of Chondrograft™, and procedural goals include regrowth of the cartilage-bone matrix, improvement in knee function and pain, and delayed need for arthroplasty. 'Achieving Health Canada approval allows us to gain the clinical data needed to take a giant step forward towards design and execution of a large pivotal North American study,' said Ben Holmes, CEO of Nanochon. 'We have the utmost confidence in Dr. Abuzgaya and his clinical team at DBJS to help us recruit the right patients and execute the trial protocol that we have so carefully designed.' While the first in human trial will take place in Canada, this represents just the first step towards a larger clinical program. 'Thousands of patients with chondral defects, that may evolve to osteoarthritis, live with a reduced quality of life. We are looking forward to the potential for a new treatment option and are excited to begin the Chondrograft™ study at DBJS,' states Dr. Joel Lobo. 'The results of this study could open up a new surgical option, that is minimally invasive to address this unmet clinical need.' Throughout the clinical trial design and regulatory approval process, Nanochon was supported by HN Clinical Consulting (Missouri). "Improving the lives of young adults and athletes by providing a solution to restore knee cartilage and hopefully help patients avoid costly knee replacement is a crucial therapy needed in the orthopedic world," said Heather Neill, Founder and Principal. "We appreciate Health Canada's thought-provoking questions throughout their review that helped us put forward the strongest application possible, which ultimately led to our approval.' HN Clinical Consulting will continue to support the full life cycle of Chondrograft™. About HN Clinical Consulting HN Clinical Consulting, LLC, brings a strategic focus to each project, keeping the goal of commercialization in sight. Building strong relationships with all stakeholders and maintaining a clinical strategic goal of project-oriented success to support long term Sponsor strategy/exit is key to development of clinical programs. The objective set is to stay ahead by planning for podium presence, publication, and reimbursement while designing the Clinical Investigational Plan. About Nanochon Nanochon is a biotech and medical device company focused on developing innovative orthopedic solutions. Chondrograft™ is a minimally-invasive 3D printed implant that has allowed for immediate weight-bearing and motion in pre-clinical studies. The implant is based on research from the Tissue Engineering and Nanotechnology lab at the George Washington University, and is designed to integrate with healthy tissue over time, for maximum stability and benefit to the patient. Nanochon has the potential to deliver more successful and longer-lasting recovery for patients than current standard of care. Our mission is to develop a new approach to treat cartilage defects so that the hundreds of thousands of young, active patients with joint damage can return to their lifestyles without undergoing costly and invasive short-term fixes.


Time Business News
2 hours ago
- Time Business News
How Prenatal Massage Supports Better Sleep During Pregnancy in the UAE
If you're pregnant and struggling to sleep through the night, you're not alone. Many expectant mothers in the UAE, especially in hot cities like Dubai and Abu Dhabi, report pregnancy insomnia as one of their biggest challenges. Whether it's due to hormonal changes, back pain, or simply the discomfort of a growing belly, poor sleep can leave you feeling exhausted. The good news? A relaxing prenatal massage can help you regulate your sleep cycle and get the rest your body—and baby—needs. Why Pregnancy Insomnia Is So Common in the UAE Living in a warm climate like the UAE's has its perks, but it also adds stress to the body—especially during pregnancy. Common causes of sleep problems during pregnancy include: Hormonal fluctuations affecting mood and restlessness Back pain, leg cramps, or hip discomfort Overheating due to UAE's high temperatures Anxiety or stress about the upcoming birth Frequent nighttime bathroom visits All of these factors can lead to interrupted or poor-quality sleep, making it difficult to feel refreshed the next day. How Prenatal Massage Improves Sleep ✅ Reduces Muscle Tension & Pain Prenatal massage focuses on relieving pressure from key areas like the lower back, hips, and legs. By releasing muscle tension, your body finds it easier to relax into a deeper, more restorative sleep. ✅ Lowers Cortisol (Stress Hormone) Levels Stress is one of the biggest sleep disruptors. A relaxing pregnancy massage has been shown to reduce cortisol and increase serotonin—your natural 'feel-good' hormone. This shift supports a more balanced mood and promotes better sleep. ✅ Improves Blood Circulation Swelling and poor circulation can be worse in warm weather. Prenatal massage stimulates circulation, helping reduce fluid retention and leg cramps that often wake you up at night. ✅ Promotes Nervous System Relaxation When done properly, massage signals the nervous system to slow down, leading to reduced heart rate, relaxed breathing, and natural drowsiness—exactly what you need to fall asleep peacefully. What Makes Prenatal Massage Different in the UAE? Many UAE-based wellness providers offer air-conditioned home visits, perfect for pregnant women who want to avoid travel in hot weather. Certified prenatal therapists in Dubai, Abu Dhabi, and Sharjah understand the regional climate and adjust their massage techniques accordingly—using light oils, cooling sheets, and side-lying positions for optimal comfort. Tips for Maximizing Sleep After a Prenatal Massage Book your massage in the evening to relax right before bedtime to relax right before bedtime Avoid screens or caffeine for at least an hour after the session for at least an hour after the session Sleep in a cool, dark room —use blackout curtains and AC if needed —use blackout curtains and AC if needed Use pregnancy pillows to support hips and belly while lying on your side Ready to Sleep Better? Your body is working overtime to grow new life. It deserves rest. Whether you're in Dubai, Abu Dhabi, or elsewhere in the UAE, consider adding prenatal massage to your sleep toolkit. Not only does it ease physical discomfort, but it also helps calm your mind—naturally leading to deeper, healthier sleep. Let your body recharge. You and your baby will both benefit. TIME BUSINESS NEWS

Business Insider
2 hours ago
- Business Insider
Albertsons CEO says cottage cheese sales are up — and it's partly due to TikTok
Albertsons is selling a lot of cottage cheese. The grocery chain's CEO thinks she knows why. "This one, I had to double-check the numbers, but cottage cheese is actually a strong growth category," CEO Susan Morris told analysts on the company's earnings call. Morris was asked whether Albertsons had noticed an increase in healthier items due to the rapid rise of GLP-1 drugs, which include Novo Nordisk's Wegovy and Ozempic. Patients who use the drugs are advised to eat protein-rich foods like cottage cheese. It's not just the diet drugs that are driving demand, though, Morris said. "Yes, some of that's from the focus on protein, lower carbs, perhaps GLP-1 users, and then, just being totally frank, TikTok is driving some of that," she said. "So, we're leaning into those categories." TikTok creators have found creative ways to get their cottage cheese fix. Good Culture, one of the top sellers, told Business Insider it noticed sales taking off in 2023 when creators talked about using cottage cheese in ice cream. Since then, popular videos have cottage cheese mixed into pancakes, bagels, and flatbread batter. On TikTok, there are more than 86,000 videos posted with the hashtag #cottagecheese. One of the most popular videos, 3 ways to make cottage cheese toast, has 5.3 million views. Albertsons is not alone in noticing this trend. Industry data shows that cottage cheese reached $1.75 billion, according to Chicago-based market research firm Circana. The data, published by the trade publication Dairy Foods, indicate that sales increased 18% in a 52-week stretch ending in Feburary. Last year, sales were up 16%. Good Culture, which launched a decade ago, told BI it recently partnered with a collection of creators, including chef and Mŏkbar owner Esther Choi, James Beard finalist Fariyal Abdullahi, and NYT bestselling author Jake Cohen. In 2024, Daisy, one of the mainstays in the space, announced a partnership with Bachelor star Daisy Kent. It wasn't always this way. According to US Department of Agriculture data, in 1975, Americans consumed an average of 4.6 pounds of cottage cheese per person. Consumption decreased in the decades since, bottoming out at an average of 1.9 pounds per person in 2021. Consumption has been rising in recent years — perhaps thanks to TikTok. In 2023, the most recent year available, Americans consumed an average of 2.1 pounds of cottage cheese per person.